Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...

Three-dimensional (3D) cancer models have emerged as pivotal tools in oncology research, offering a more accurate representation of tumor biology compared ...

AstraZeneca AZN is one of the leading drugmakers in the oncology space. Oncology sales (comprising around 41% of ...

People are going on social media to share their belief that this antiparasitic drug can fight cancer. Learn what the science ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

The Food and Drug Administration (FDA) has added more medicines for cancer, diabetes, high cholesterol, hypertension, and mental illness in its list of drugs exempted from value-added tax (VAT).

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth up to $25 billion.

Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.

Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives By Robert Langreth Tanaz Meghjani Rachael Dottle May 28, 2025 ...

The U.S. Food and Drug Administration this week granted permission for the use of a new cancer drug from China despite high-profile strains in ties between the two countries. Akeso said on Friday ...

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the ...